Key Takeaways

• Douglas Group achieved a 3.2% sales increase in Q3 2024/25, reaching €1.0 billion.
• Excluding the Disapo pharmacy sale, sales rose 4%, fueled by an 8.2% increase in e-commerce.
• Net income improved significantly to €17.3 million, reversing a €71.6 million loss from last year.

Sales Growth Returns

Douglas Group has reported a 3.2% year-over-year increase in sales for Q3 2024/25, reaching a total of €1.0 billion, indicating a return to growth following a decline in Q2. The company has also reaffirmed its full-year guidance, showcasing its resilience in a fluctuating market.

When excluding the sale of the online pharmacy Disapo, Douglas’s sales rose 4%. This growth was largely driven by an 8.2% increase in e-commerce and a 2.1% rise in physical store sales. The Central Eastern European markets were pivotal, demonstrating a strong gain of 10.5%. However, there was a slight decrease in demand in France, where sales fell by 0.9%.

Net Income and Overall Performance

The company’s net income showcased a robust improvement, reaching €17.3 million compared to a significant loss of €71.6 million in the previous year. Over the first three quarters of the fiscal year, total sales amounted to €3.6 billion, marking a 2.9% increase. The company’s EBITDA also experienced positive growth, rising by 8.5% during this period.

Omnichannel Expansion

In alignment with its “Let it Bloom” strategy, Douglas continues to enhance its omnichannel network. In Q3, the company opened 22 new stores and refurbished 39 existing locations, further strengthening its retail presence.

Outlook

The consistent growth across key markets and robust online performance underline Douglas’s improving profitability and affirm its optimistic outlook for the fiscal year 2024/25. As the company capitalizes on these trends, it remains focused on expanding its footprint and leveraging its omnichannel capabilities.

The content above is a summary. For more details, see the source article.